Transcription of Allergen immunotherapy: A practice parameter third update
{{id}} {{{paragraph}}}
Task force reportAllergen immunotherapy: A practice parameter third updateChief Editors: Linda Cox, MD, Harold Nelson, MD, and Richard Lockey, MDWorkgroup Contributors: Christopher Calabria, MD, Thomas Chacko, MD, Ira Finegold, MD, Michael Nelson, MD, PhD,and Richard Weber, MDTask Force Reviewers: David I. Bernstein, MD, Joann Blessing-Moore, MD, David A. Khan, MD, David M. Lang, MD,Richard A. Nicklas, MD, John Oppenheimer, MD, Jay M. Portnoy, MD, Christopher Randolph, MD, Diane E. Schuller, MD,Sheldon L. Spector, MD, Stephen Tilles, MD, and Dana Wallace, MDKeywords:Allergy immunotherapy, subcutaneous immunotherapy,sublingual immunotherapy, allergic rhinitis, asthma, Hymenoptera,atopic dermatitis, anaphylaxis, epinephrine,b-blockers, angioten-sin-converting enzyme inhibitor, epicutaneous immunotherapy, in-tralymphatic immunotherapy, nasal immunotherapyThese parameters were developed by the Joint Task Force onPractice Parameters, representing the American Academy ofAllergy, Asthma & Immunology (AAAAI); the American Col-lege of Allergy, Asthma & Immunology (ACAAI); and the JointCouncil of Allergy, Asthma & Immunology.
and on the advisory board for ALK America, is on the advisory board for Merck, ... New Haven, Connecticut Diane E. Schuller, MD Department of Pediatrics Pennsylvania State University ... Northwestern University Feinberg School of Medicine Chicago, Illinois Bryan Martin, DO Ohio State University Columbus, Ohio PREFACE
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}